Literature DB >> 30763733

Modified oral enteric-coated budesonide regimens to treat pediatric eosinophilic gastroenteritis, a single center experience.

Katie Kennedy1, Amanda B Muir2, Andrew Grossman2, Terri Brown-Whitehorn3, Antonella Cianferoni3, Jonathan M Spergel3, Glenn T Furuta4, Benjamin J Wilkins5, Michele Shuker6, Melanie A Ruffner3.   

Abstract

Entities:  

Year:  2019        PMID: 30763733      PMCID: PMC7064262          DOI: 10.1016/j.jaip.2019.01.053

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  8 in total

1.  Eosinophilic gastroenteritis with severe protein-losing enteropathy: successful treatment with budesonide.

Authors:  E Siewert; F Lammert; P Koppitz; T Schmidt; S Matern
Journal:  Dig Liver Dis       Date:  2005-12-01       Impact factor: 4.088

2.  Localized eosinophilic ileitis with mastocytosis successfully treated with oral budesonide.

Authors:  C Lombardi; A Salmi; A Savio; G Passalacqua
Journal:  Allergy       Date:  2007-11       Impact factor: 13.146

3.  "Triple Phase" Budesonide Capsules for the Treatment of Olmesartan-Induced Enteropathy.

Authors:  Megan E Hartranft; Randolph E Regal
Journal:  Ann Pharmacother       Date:  2014-06-23       Impact factor: 3.154

4.  Variation in prevalence, diagnostic criteria, and initial management options for eosinophilic gastrointestinal diseases in the United States.

Authors:  Jonathan M Spergel; Wendy M Book; Elizabeth Mays; Lihal Song; Samir S Shah; Nicholas J Talley; Peter A Bonis
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-03       Impact factor: 2.839

Review 5.  Eosinophilic gastrointestinal diseases beyond eosinophilic esophagitis.

Authors:  Maureen Egan; Glenn T Furuta
Journal:  Ann Allergy Asthma Immunol       Date:  2018-06-22       Impact factor: 6.347

Review 6.  Efficacy of Dietary Treatment for Inducing Disease Remission in Eosinophilic Gastroenteritis.

Authors:  Alfredo J Lucendo; Beatriz Serrano-Montalbán; Ángel Arias; Olga Redondo; José M Tenias
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-07       Impact factor: 2.839

7.  Prevalence of Eosinophilic Gastritis, Gastroenteritis, and Colitis: Estimates From a National Administrative Database.

Authors:  Elizabeth T Jensen; Christopher F Martin; Michael D Kappelman; Evan S Dellon
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-01       Impact factor: 2.839

8.  Eosinophilic gastroenteritis treated with non-enteric-coated budesonide tablets.

Authors:  A C Tan; J W Kruimel; T H Naber
Journal:  Eur J Gastroenterol Hepatol       Date:  2001-04       Impact factor: 2.566

  8 in total
  5 in total

1.  Eosinophilic Gastrointestinal Diseases Beyond Eosinophilic Esophagitis.

Authors:  Evan S Dellon
Journal:  Am J Gastroenterol       Date:  2022-01-25       Impact factor: 12.045

Review 2.  Eosinophilic Gastritis/Gastroenteritis.

Authors:  Phillip H Chen; Lorraine Anderson; Kuixing Zhang; Guy A Weiss
Journal:  Curr Gastroenterol Rep       Date:  2021-07-30

Review 3.  Eosinophilic gastrointestinal disease below the belt.

Authors:  Robert D Pesek; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2019-10-24       Impact factor: 10.793

4.  Collagenous Gastritis Masquerading as Eosinophilic Gastritis.

Authors:  Jeremy Klein; Benjamin J Wilkins; Ritu Verma; Amanda B Muir
Journal:  ACG Case Rep J       Date:  2021-02-22

5.  Eosinophilic Gastroenteritis-associated Duodenal Ulcer Successfully Treated with Crushed Budesonide.

Authors:  Kimitoshi Kubo; Noriko Kimura; Katsuhiro Mabe; Soichiro Matsuda; Momoko Tsuda; Mototsugu Kato
Journal:  Intern Med       Date:  2020-06-15       Impact factor: 1.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.